# Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)

> **NCT03302299** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 302 (actual)

## Conditions studied

- Tuberculosis
- HIV/AIDS
- Alcohol Abuse

## Interventions

- **DRUG:** Isoniazid 300 Mg ORAL TABLET
- **DRUG:** Pyridoxine 25 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT03302299
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-07
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2023-10-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03302299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03302299, "Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03302299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*